Blastomyces dermatitidis Gilchrist et Stokes, anamorph
Strain Designations
CDC B-3017 [M-268]
Alternate State
Ajellomyces dermatitidis McDonough et Lewis
Application
Biomedical Research and Development Material
Emerging infectious disease research
Biosafety Level
3
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
frozen
Type Strain
no
Antigenic Properties
serotype 2, serotype 2
RefKaufman L, et al. Detection of two Blastomyces dermatitidis serotypes by exoantigen analysis. J. Clin. Microbiol. 18: 110-114, 1983. PubMed: 6411760
Preceptrol®
no
Medium
ATCC® Medium 336: Potato dextrose agar (PDA)
Growth Conditions
Temperature: 26.0°C
Name of Depositor
AA Padhye
Chain of Custody
ATCC <<--AA Padhye<<--F. Mariat M-268
Isolation
human, Tunisia
References
Kaufman L, et al. Detection of two Blastomyces dermatitidis serotypes by exoantigen analysis. J. Clin. Microbiol. 18: 110-114, 1983. PubMed: 6411760
Kaufman L, et al. Detection of two Blastomyces dermatitidis serotypes by exoantigen analysis. J. Clin. Microbiol. 18: 110-114, 1983. PubMed: 6411760